Tandem Diabetes Care, Inc. (TNDM) is a publicly traded Healthcare sector company. As of May 21, 2026, TNDM trades at $14.89 with a market cap of $927.20M and a P/E ratio of -10.46. TNDM moved +8.51% today. Year to date, TNDM is -35.03%; over the trailing twelve months it is -36.05%. Its 52-week range spans $9.98 to $45.28. Analyst consensus is buy with an average price target of $30.76. Rallies surfaces TNDM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes TNDM SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $14.89 |
| Market Cap | $927.20M |
| P/E Ratio | -10.46 |
| EPS | $-1.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $45.28 |
| 52-Week Low | $9.98 |
| Volume | 2.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.03B |
| Net Income | $-94.55M |
| Gross Margin | 54.93% |
18 analysts cover TNDM: 0 strong buy, 9 buy, 9 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.76.